Table 1.
Characteristic | |
---|---|
Age (years) – median (range) | 28.5 (5–81) |
Sex – n (%) | |
Male | 69 (53.9%) |
Female | 59 (46.1%) |
Bulky disease – n (%) | |
Present | 27 (21.1%) |
Absent | 101 (78.9%) |
Subtype – n (%) | |
Nodular sclerosis | 75 (58.6) |
Mixed cellularity | 23 (18.0) |
Lymphocyte-rich | 5 (3.9) |
Lymphocyte depleted | 3 (2.3) |
Unclassified | 22 (17.2) |
Clinical stage – n (%) | |
I | 16 (11.7) |
II | 38 (29.7) |
III | 35 (27.3) |
IV | 40 (31.3) |
IPS score – n (%) | |
0–3 | 98 (76.6) |
4–7 | 30 (23.4) |
Disease status – n (%) | |
Early disease | 45 (35.2) |
Advanced disease | 83 (64.8) |
IPS: International Prognostic Score.